Evidence map›Paper›PMID 34941967›Full record

ArticlePLoS pathogens2021

Curcumin activation of a bacterial mechanosensitive channel underlies its membrane permeability and adjuvant properties.

Robin Wray, Irene Iscla, Paul Blount

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. The Multifaceted Actions of PVP-Curcumin for Treating Infections.International journal of molecular sciences · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Robin WrayDepartment of Physiology, UT Southwestern Medical Center, Dallas, Texas, United States of America.ORCID 0000-0002-1337-0663
Irene IsclaDepartment of Physiology, UT Southwestern Medical Center, Dallas, Texas, United States of America.ORCID 0000-0001-8936-430X
Paul BlountDepartment of Physiology, UT Southwestern Medical Center, Dallas, Texas, United States of America.ORCID 0000-0001-5259-4881
Southwestern Medical Center · US

Funding

Using Small Compounds as Probes for Studying Mechanosensitive Channel GatingR01GM121780 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI BLOUNT, PAUL · 2017 to 2020
$1.1M
NIGMS NIH HHS R01 GM121780
6 · The paper itself

Abstract

Curcumin, a natural compound isolated from the rhizome of turmeric, has been shown to have antibacterial properties. It has several physiological effects on bacteria including an apoptosis-like response involving RecA, membrane permeabilization, inhibiting septation, and it can also work synergistically with other antibiotics. The mechanism by which curcumin permeabilizes the bacterial membrane has been unclear. Most bacterial species contain a Mechanosensitive channel of large conductance, MscL, which serves the function of a biological emergency release valve; these large-pore channels open in response to membrane tension from osmotic shifts and, to avoid cell lysis, allow the release of solutes from the cytoplasm. Here we show that the MscL channel underlies the membrane permeabilization by curcumin as well as its synergistic properties with other antibiotics, by allowing access of antibiotics to the cytoplasm; MscL also appears to have an inhibitory role in septation, which is enhanced when activated by curcumin.

Indexed as

Anti-Bacterial AgentsBacillus subtilisCell MembraneCell Membrane PermeabilityCurcuminEscherichia coliEscherichia coli ProteinsIon ChannelsAnti-Bacterial AgentsCurcuminEscherichia coli ProteinsIon ChannelsMscL protein, E coli

Identifiers

PMID34941967
PMCPMC8769312
OpenAlexW4200201596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.